Pharmaceutical behemoth Eli Lilly (LLY) smashed Wall Street’s third-quarter expectations and raised its full-year outlook Thursday, thanks to its diabetes and obesity treatments. “Arguably the stron… [+3527 chars]Read More
Palantir Earnings Due As Nvidia Broadcom Shake Off Trump Tariffs Investors Business Daily
With Palantir in focus, fellow AI stocks Nvidia and Broadcom rebound.
